MITIG.RA:针对类风湿关节炎疲劳管理的定制心理干预随机对照试验研究方案
MITIG.RA为单中心两臂平行随机对照试验,针对PGA接近缓解但仍疲劳的类风湿关节炎患者,比较慈悲与正念干预联合常规治疗与单用常规治疗的疗效。干预由认证心理师实施八次2小时课程加两次强化课程,主要结局为疲劳,次要结局包括疾病感知影响、抑郁症状等,随访至第44周。
要点
- 针对PGA接近缓解但疲劳突出的类风湿关节炎患者设计。
- 干预为慈悲与正念干预联合常规治疗,对照为单用常规治疗。
- 主要结局为疲劳,评估时间包括基线、干预后及第12、20、32、44周。
核心结论
- 研究预期MITIG.RA能有效降低类风湿关节炎相关疲劳水平。
- 研究假设实验组在疾病总体感知影响、情绪困扰和情绪调节技能方面将显示改善。
研究设计与样本
- 单中心、两臂平行随机对照试验,采用计算机随机分组。
- 患者经资格和参与意愿筛选后,随机分入实验组(MITIG.RA联合常规治疗)或对照组(单用常规治疗)。
- MITIG.RA由认证心理师实施,包括八次每次2小时的课程,随后两次强化课程。
- 评估采用经验证的自评量表,包括疲劳(主要结局)、疾病感知影响、抑郁症状、正念、自我慈悲、安全性和满意度(次要结局)。
- 评估时间点为基线、干预后、第一次和第二次强化课程前(分别为第12周和第20周),以及干预开始后第32周和第44周。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite remarkable medical advances in the treatment of rheumatoid arthritis (RA), a subset of patients fails to achieve complete clinical remission, as the Patient Global Assessment (PGA) of disease activity remains above 1, even after the inflammatory process is brought under control. This so-called state of 'PGA-near-remission' negatively impacts individuals' functioning and potentiates inadequate care. Fatigue is a distressing and disabling symptom frequently reported by patients in PGA-near-remission, and its management remains challenging. While classic cognitive-behavioural interventions show some benefits in managing fatigue, there is potential for improvement. Recently, contextual-cognitive behavioural therapies (CCBT), like mindfulness, acceptance, and compassion-based interventions, have shown promising results in fatigue-associated disorders and their determinants. This study primarily aims to examine the efficacy of the Compassion and Mindfulness Intervention for RA (MITIG.RA), a novel intervention combining different components of CCBT, compared to treatment-as-usual (TAU) in the management of RA-associated fatigue. Secondary aims involve exploring whether MITIG.RA produces changes in the perceived impact of disease, satisfaction with disease status, levels of depression, and emotion-regulation skills. METHODS: This is a single center, two-arm parallel randomized controlled trial. Patients will be screened for eligibility and willingness to participate and will be assessed and randomized to the experimental (MITIG.RA + TAU) or control condition (TAU) using computer randomization. MITIG.RA will be delivered by a certified psychologist and comprises eight sessions of 2 h, followed by two booster sessions. Outcomes will be assessed through validated self-report measures, including fatigue (primary outcome), perceived impact of disease, depressive symptoms, mindfulness, self-compassion, safety, and satisfaction (secondary outcomes). Assessment will take place at baseline, post-intervention, before the first and second booster sessions (weeks 12 and 20, respectively), and at 32 and 44 weeks after the interventions' beginning. DISCUSSION: We expect MITIG.RA to be effective in reducing levels of RA-associated fatigue. Secondarily, we hypothesize that the experimental group will show improvements in the overall perceived impact of disease, emotional distress, and emotion regulation skills. Our findings will contribute to determine the benefits of combining CCBT approaches for managing fatigue and associated distress in RA. TRIAL REGISTRATION: ClinicalTrials.gov NCT05389189. Registered on May 25, 2022.
引用
- Duarte C, Spilker RLF, Paiva C, et al. MITIG.RA: study protocol of a tailored psychological intervention for managing fatigue in rheumatoid arthritis randomized controlled trial. Trials. 2023. PMID: 37803467. doi:10.1186/s13063-023-07692-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。